Silicone-based biophotonic compositions and uses thereof
The present disclosure provides silicone-based biophotonic compositions and methods useful in phototherapy. In particular, the silicone-based biophotonic compositions of the present disclosure include a silicone phase and a surfactant phase, wherein the surfactant phase comprises at least one chromophore solubilized in a surfactant. The silicone-based biophotonic compositions and the methods of the present disclosure are useful for promoting wound healing and scarring, as well as various other skin disorders.
1. A silicone-based biophotonic membrane comprising a silicone phase and a thermogellable surfactant phase, wherein the thermogellable surfactant phase comprises at least one chromophore solubilized in a surfactant;
wherein the silicone-based biophotonic membrane comprises between 80-99 wt % silicone phase and between 1-20 wt % thermogellable surfactant phase;
wherein the silicone-based biophotonic membrane when exposed to actinic light having a wavelength of between about 400 nm and about 800 nm emits fluorescence;
wherein the silicone-based biophotonic membrane has a light transmittance of between about 90% and about 100%: and
wherein the silicone-based biophotonic membrane has a thickness of between about 0.5 mm and about 20 mm, a tensile strength of at least about 50 kPa, and a tear strength of from about 0.1 N/mm to about 5 N/mm.
2. The silicone-based biophotonic membrane of claim 1 , wherein the thermogellable surfactant phase is emulsified in the silicone phase.
3. The silicone-based biophotonic membrane of claim 1 , wherein the surfactant comprises a block copolymer, wherein the block copolymer comprises at least one hydrophobic block and at least one hydrophilic block.
4. The silicone-based biophotonic membrane of claim 1 , wherein the surfactant comprises at least one sequence selected from the group consisting of polyethylene glycol-propylene glycol ((PEG)-(PPG)), polyethylene glycol-polylactic acid (PEG)-(PLA), polyethylene glycol-poly(lactic-c-glycolic acid) (PEG)-(PLGA), and polyethyelene glycol-polycaprolactone (PEG)-(PCL).
5. The silicone-based biophotonic membrane of claim 4 , wherein the surfactant is a poloxamer.
6. The silicone-based biophotonic membrane of claim 1 , wherein the thermogellable surfactant phase further comprises a surfactant selected from the group consisting of cetyl trimethylammonium bromide (CTAB) and sodium dodecyl sulfate (SDS).
7. The silicone-based biophotonic membrane of claim 1 , wherein the chromophore is a cationic chromophore selected from the group consisting of cyanine, acridine and pyronine Y.
8. The silicone-based biophotonic membrane of claim 1 , wherein the chromophore is Eosin Y.
9. The silicone-based biophotonic membrane of claim 1 , wherein the thermogellable surfactant phase further comprises a stabilizer selected from the group consisting of gelatin, hydroxylethyl cellulose (HEC), carboxymethyl cellulose (CMC), and a thickening agent.
10. The silicone-based biophotonic membrane of claim 1 , wherein the silicone phase comprises a polydimethylsiloxane polymer (PDMS).
11. The silicone-based biophotonic membrane of claim 10 , wherein the content of the PDMS in the silicone phase is from about 5 wt % to about 100 wt %.
12. A method for biophotonic skin treatment, comprising:
placing a silicone-based biophotonic membrane over a target skin tissue, wherein the silicone-based biophotonic membrane comprises a silicone phase and a thermogellable surfactant phase, and wherein the thermogellable surfactant phase comprises at least one chromophore solubilized in a surfactant; wherein the silicone-based biophotonic membrane comprises between 80-99 wt % silicone phase and between 1-20 wt % thermogellable surfactant phase; and wherein the silicone-based biophotonic membrane has a light transmittance of between about 90% and about 100%; and wherein the silicone-based biophotonic membrane has a thickness of between about 0.5 mm and about 20 mm, a tensile strength of at least about 50 kPa, and a tear strength of from about 0.1 N/mm to about 5 N/mm; and
illuminating said silicone-based biophotonic membrane with light having a wavelength of between about 400 nm and about 800 nm; wherein the silicone-based biophotonic membrane when exposed to the actinic light having the wavelength that overlaps with the absorption spectrum of the at least one chromophore emits fluorescence.
13. The method of claim 12 , wherein the skin treatment comprises treating a skin disorder selected from the group consisting of acne, eczema, psoriasis, and dermatitis.
14. The method of claim 12 , wherein the skin treatment comprises promoting skin rejuvenation.
15. The method of claim 12 , wherein the silicone-based biophotonic membrane is illuminated until the chromophore is at least partially photobleached.
16. A method for promoting wound healing comprising:
placing a silicone-based biophotonic membrane over a wound, wherein the silicone-based biophotonic membrane comprises a silicone phase and a thermogellable surfactant phase, and wherein the thermogellable surfactant phase comprises at least one chromophore solubilized in a surfactant; wherein the silicone-based biophotonic membrane comprises between 80-99 wt % silicone phase and between 1-20 wt % thermogellable surfactant phase; wherein the silicone-based biophotonic membrane has a light transmittance of between about 90% and about 100%; and wherein the silicone-based biophotonic membrane has a thickness of between about 0.5 mm and about 20 mm, a tensile strength of at least about 50 kPa, and a tear strength of from about 0.1 N/mm to about 5 N/mm; and
illuminating said silicone-based biophotonic membrane with light having a wavelength of between about 400 nm and about 800 nm; wherein the silicone-based biophotonic membrane when exposed to the actinic light emits fluorescence.
17. The method of claim 16 , wherein the method comprises treating or preventing scarring.